Helsinn Healthcare S.A.: Helsinn publishes results from a se

Helsinn publishes results from a secondary analysis of a Phase 3 trial in patients with CINV in The Oncologist Lugano, Switzerland, January 4, 2023 - Helsinn Group ("Helsinn")

Related Keywords

China , Lugano , Ticino , Switzerland , United States , Ireland , Alex Molassiotis , Paola Bonvicini , Eros Papademetriou , Kelseya Klute , Lee Schwartzberg , Luke Schmerold , Kostenloser Wertpapierhandel , Dwightd Kloth , Gary Binder , Thomasw Leblanc , Ericj Roeland , Rudolph Navari , Linkedin , Group Head Of Communication , Twitter , Helsinn Group , Helsinn Birex Pharmaceuticals Ltd , Later Cycles , Oxford Academic , Specific Populations , Helsinn Birex Pharmaceuticals , Media Contact , Group Head , Helsinn , Healthcare , Ublishes , Results , Rom , Secondary , Analysis , Hase , Trial , Patients , Ginv ,